PARTNERS clinical trial initiates patient enrollment for Bundibugyo virus disease treatments in DRC

The WHO-backed PARTNERS trial has commenced patient enrollment in the Democratic Republic of the Congo to evaluate therapeutic interventions for the Bundibugyo virus. This marks the first systematic effort to identify effective treatments for this specific Ebola-related pathogen, though clinical efficacy remains unproven.